PROVISION OF BETA INTERFERON

Motion Text

That this House notes the issuing of Health Service Circular 1999/999 on the multiple sclerosis drug Beta Interferon; believes that this circular represents a further withdrawal from the Government's pledge of universal care for those that need it; finds the circular pre-empts proper consideration by the National Institute for Clinical Excellence; and opposes any further moves to ration drugs available on the NHS on grounds of cost rather than clinical effectiveness.